FDA eyes Nexium, Prilosec for heart risks with early communication
August 09 2007
The Food and Drug Administration flagged potential cardiovascular risks with AstraZenecas Nexium and its predecessor, Prilosec, but said it has ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.